Article Figures & Data
Tables
- Table 1
The basic information of patients (n=118)
Items Cases Sex Female 118 Male 0 Age ≤40 years old 12 40 years old and ≤60 years old 62 >60 years old 44 Therapeutic regime AT 75 TAC 43 Patients with hypertension, coronary heart disease or diabetes before chemotherapy 0 The total number of patients 118 - Table 2
Analysis of the echocardiograms of the patients before, during and after chemotherapy
Clinical characteristics Before chemotherapy ( 
̄±s)During chemotherapy (
±s)After chemotherapy (
±s)F(B) or χ² P12 P13 P23 LVEF (%) 64.458±3.713 64.169±3.314 63.992±3.636 0.598(B) 0.896 0.700 0.971 LAMAD (mm) 31.508±3.486 31.915±3.988 31.966±4.118 0.610(B) 0.789 0.734 1.000 RAMD (mm) 29.619±2.276 29.644±2.567 29.542±2.395 0.945(B) 1.000 0.992 0.985 LVEDD (mm) 42.203±3.014 42.115±3.346 41.915±3.107 0.773(B) 0.995 0.851 0.951 LVESD (mm) 26.822±2.797 27.000±2.897 27.195±2.596 0.585(B) 0.950 0.640 0.929 RVID (mm) 14.627±1.642 14.814±2.335 15.093±3.320 0.363 0.571 0.158 0.396 P12, P13 and P23 represent the calculation results of corresponding tests for indicators before and during chemotherapy, before and after chemotherapy, and during and after chemotherapy, respectively.
LAMAD, left atrial maximum anteroposterior diameter; LVEDD, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic diameter; RAMD, right atrial mediolateral diameter; RVID, right ventricular internal dimension.
- Table 3
Analysis of the echocardiograms of the patients before, during and after chemotherapy
Clinical characteristics Before chemotherapy (
±s)During chemotherapy (
±s)After chemotherapy (
±s)F(B) or χ² P12 P13 P23 Heart rate
(times/min)74.017±11.195 80.627±13.391 81.373±13.312 <0.001(B) <0.001 <0.001 0.963 P-wave time (s) 0.107±0.010 0.106±0.013 0.105±0.011 0.193(B) 0.632 0.153 0.875 P-R interphase (s) 0.152±0.020 0.153±0.019 0.151±0.018 0.696(B) 1.000 0.871 0.801 QRS complex (s) 0.086±0.010 0.086±0.008 0.086±0.008 0.968(B) 0.995 1.000 0.993 Q-T interphase (s) 0.399±0.036 0.398±0.040 0.397±0.040 0.891(B) 0.989 0.948 0.989 P12, P13 and P23 represent the calculation results of corresponding tests for indicators before and during chemotherapy, before and after chemotherapy, and during and after chemotherapy, respectively.
- Table 4
Statistical analysis results of ST-segment abnormalities and T wave abnormalities
Clinical characteristics Before chemotherapy (%) During chemotherapy (%) After chemotherapy (%) P12 P13 P23 ST-segment abnormalities 16.95 25.42 34.75 0.111 0.002 0.118 T wave abnormalities 27.12 26.27 37.29 0.883 0.095 0.069 P12, P13 and P23 represent the calculation results of corresponding tests for indicators before and during chemotherapy, before and after chemotherapy, and during and after chemotherapy, respectively.
- Table 5
Statistical analysis of myocardial enzymes
Clinical characteristics Before chemotherapy (
±s)During chemotherapy (
±s)After chemotherapy (
±s)F(B) or χ² P12 P13 P23 Creatine kinase (U/L) 42.555±15.340 43.892±25.467 53.331±37.024 0.005 0.708 0.003 0.009 Creatine kinase isoenzyme (U/L) 11.678±6.787 11.794±6.107 11.748±5.857 0.990(B) 0.999 1.000 1.000 Lactate dehydrogenase (U/L) 180.118±36.402 179.927±35.885 192.522±42.150 0.016(B) 1.000 0.048 0.042 P12, P13 and P23 represent the calculation results of corresponding tests for indicators before and during chemotherapy, before and after chemotherapy, and during and after chemotherapy, respectively.
- Table 6
Statistical analysis of blood tests
Clinical characteristics Before chemotherapy (
±s)During chemotherapy (
±s)After chemotherapy (
±s)F(B) or χ² P12 P13 P23 Hemoglobin (g/L) 129.280±12.762 115.381±12.752 116.881±12.900 <0.001(B) <0.001 <0.001 0.749 Albumin (g/L) 42.636±3.932 39.973±3.633 40.080±4.127 <0.001(B) <0.001 <0.001 0.995 P12, P13 and P23 represent the calculation results of corresponding tests for indicators before and during chemotherapy, before and after chemotherapy, and during and after chemotherapy, respectively.
- Table 7
Statistical analysis of blood tests
Clinical characteristics Before chemotherapy (
±s)During chemotherapy (
±s)After chemotherapy (
±s)F(B) or χ² P12 P13 P23 Fasting blood glucose (mmol/L) 5.632±2.180 5.391±1.385 5.660±2.004 0.484(B) 0.672 0.999 0.544 P12, P13 and P23 represent the calculation results of corresponding tests for indicators before and during chemotherapy, before and after chemotherapy, and during and after chemotherapy, respectively.
- Table 8
Statistical analysis of blood tests
Clinical characteristics Before chemotherapy (
±s)During chemotherapy (
±s)After chemotherapy (
±s)F(B) or χ² P12 P13 P23 Total cholesterol (mmol/L) 5.695±4.042 5.557±1.032 5.566±1.050 0.892(B) 0.978 0.982 1.000 Triglyceride (mmol/L) 1.360±0.637 1.903±1.071 1.939±0.843 <0.001 <0.001 <0.001 0.748 Low-density lipoprotein (mmol/L) 3.388±0.863 3.461±0.928 3.506±0.901 0.594(B) 0.895 0.663 0.975 High-density lipoprotein (mmol/L) 1.519±0.356 1.451±0.324 1.396±0.340 0.021(B) 0.325 0.020 0.494 P12, P13 and P23 represent the calculation results of corresponding tests for indicators before and during chemotherapy, before and after chemotherapy, and during and after chemotherapy, respectively.
